CStone Pharmaceuticals
02616
Company Profile
Business description
CStone Pharmaceuticals is engaged in developing and commercializing of immuno-oncology and molecularly targeted drugs to address unmet medical needs in cancer treatment.
Contact
218 Xinghu Street
C1 Building, North Block
Suzhou Industrial Park
Suzhou215123
CHNT: +86 51287186550
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
131
Stocks News & Analysis
stocks
ASX reporting season wrap: BHP, banks, CSL bloodbath and more
A round up of notable stories and reactions as ASX earnings season continues.
stocks
Stock showdown: How do ASX healthcare giants compare on key investing criteria?
Our healthcare analyst Shane Ponraj helps me compare the moatiness and growth prospects of two sector heavyweights.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,234.30 | 55.70 | -0.60% |
| CAC 40 | 7,969.69 | 31.40 | 0.40% |
| DAX 40 | 24,363.09 | 69.75 | 0.29% |
| Dow JONES (US) | 45,631.74 | 846.24 | 1.89% |
| FTSE 100 | 9,321.40 | 12.20 | 0.13% |
| HKSE | 25,339.14 | 234.53 | 0.93% |
| NASDAQ | 21,496.54 | 396.22 | 1.88% |
| Nikkei 225 | 42,633.29 | 23.12 | 0.05% |
| NZX 50 Index | 13,042.76 | 151.31 | -1.15% |
| S&P 500 | 6,466.91 | 96.74 | 1.52% |
| S&P/ASX 200 | 8,967.40 | 57.00 | -0.63% |
| SSE Composite Index | 3,825.76 | 54.66 | 1.45% |